Lung Cancer Outcome And Response To Treatment Predicted By Breast Cancer Susceptibility Gene
Sep 28th 2007Drug InformationBreast Cancer
Researchers have found that the breast cancer susceptibility gene, BRCA1, plays a significant role in non-small cell lung cancer (NSCLC). Not only can it be used to predict outcome for patients with NSCLC, but it may also prove to be a valuable tool in choosing the best therapy for them. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
